『070: The Cancer Test Most Patients Don't Know Exists: BLOODPAC』のカバーアート

070: The Cancer Test Most Patients Don't Know Exists: BLOODPAC

070: The Cancer Test Most Patients Don't Know Exists: BLOODPAC

無料で聴く

ポッドキャストの詳細を見る

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 In this episode, we explore a quiet revolution underway in cancer care. Instead of a painful biopsy or months of anxious waiting between scans, a single vial of blood may be able to indicate whether cancer is present, whether it is responding to treatment, or whether it has returned. The technology is here today. Most patients do not know it exists. Two women sit on opposite sides of the same mission: one builds the infrastructure that makes cancer blood tests trustworthy, the other depends on that infrastructure to know if her cancer is coming back. Lauren C. Leiman is the Executive Director of BLOODPAC, the Blood Profiling Atlas in Cancer, a consortium of industry, academic, regulatory, patient advocacy, and professional society stakeholders working to ensure liquid biopsy tests are designed and validated in a way that fosters clinician trust and improves patient care. Lauren came to this work from the White House Cancer Moonshot. Mary Royal is a breast cancer survivor and patient advocate diagnosed in late 2023 through a routine mammogram she almost canceled. After bilateral mastectomy, chemotherapy, and 38 sessions of radiation, her oncologist recommended a Personalis ctDNA test that creates a personalized molecular fingerprint of her cancer and screens for traces of recurrence in her bloodstream. Mary was initially hesitant. She describes more than 13 tests since January 2024, and what once felt like a source of anxiety has become a source of reassurance. She calls herself “Mary 2.0,” her second chance. Together, Lauren and Mary discuss what liquid biopsy is, the emotional reality of choosing to know, the difference between treatment selection, molecular residual disease (MRD), and multi-cancer early detection, the access gap that leaves patients in rural and underserved communities without these tests, and Mary's reflection that patients today are still launching to the moon while patients in just a few years will already be on it. Featured Guests: Lauren C. Leiman, Executive Director, BLOODPAC; Mary Royal, Breast Cancer Survivor and Patient Advocate Lauren previously served on the White House Cancer Moonshot Task Force, during the Obama Administration, with prior experience on Wall Street and in philanthropy. Mary is a marathon runner, mom of four, and works at a child advocacy center. Key Topics: · Mary's diagnosis: an almost-canceled mammogram in 2023 · Bilateral mastectomy, chemotherapy, and 38 sessions of radiation · What liquid biopsy is and how ctDNA testing works · Mary's experience with more than 13 ctDNA tests over two years · The emotional reality of monitoring for recurrence · “What is the point of science if we don't use it?” · Treatment selection, MRD, and multi-cancer early detection · The accessibility gap between academic centers and rural communities · BLOODPAC's expansion into hematology · The multi-omics, multi-modal future of precision medicine · What “believe in progress” means to Mary Timestamps: 00:00 Introduction 02:32 Mary's diagnosis: an almost-canceled mammogram 04:51 A marathon runner who never saw cancer coming 06:55 The “free fall” after diagnosis 07:38 Hormone-positive, HER2-negative 09:48 Treatment timeline: chemotherapy and 38 sessions of radiation 10:23 What liquid biopsy is 11:54 January 2024: Mary is introduced to ctDNA testing 13:23 The anxiety of choosing to know 15:46 Mary begins ctDNA monitoring with Personalis 16:16 From anxiety to reassurance 20:29 Lauren's origin story and the early industry 21:27 MRD as BLOODPAC's next big goal 23:37 Why accessibility became a priority 29:36 BLOODPAC's new study on access disparities 33:46 Mary on advocacy and patient forums 36:34 “Launching to the moon” 37:18 BLOODPAC approaches its 10-year anniversary 40:18 87 member organizations, including the AACR 40:57 What “believe in progress” means 41:33 Closing Take Action: · Donate to the AACR: https://donate.aacr.org/BelieveinProgress/Donate · Learn more about BLOODPAC: https://www.bloodpac.org · Subscribe to Believe in Progress: o Apple Podcasts: https://apple.co/4rLQyB5 o Spotify: https://sptfy.in/o700 o YouTube: https://AACR.org/BelieveInProgress Production Credits: Host: Mitch Stoller Guests: Lauren C. Leiman, Executive Director, BLOODPAC; Mary Royal, Breast Cancer Survivor Executive Producer: Anthony Lopes Executive Producer: Michael Leary Producer: Mitch Stoller Producer: Heather Holland Director: Anthony Lopes Creative Director / Director of Photography: Michael Leary Writer: Anthony Lopes Editor: Michael Leary Believe in Progress is produced by CollegeCast LLC for the AACR Foundation. Check out more episodes: https://AACR.org/BelieveInProgress
まだレビューはありません